NATCO Pharma Ltd 2018 Annual Report with Sustainability Disclosures
Company: NATCO Pharma Ltd
Sector: Manufacturing
Country: India
Year: 2018
Type: Annual Report with Sustainability Disclosures
Pages: 103
The report highlights FY 2017-18 consolidated total revenues of ₹22,424 million and the launch of complex generic products in the US. It describes ₹69.02 million in CSR spending through community programmes in education, health and livelihoods. The company also reports expanded renewable-energy use across its units, supported by solar and wind initiatives.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.